agilon health, inc. revised earnings guidance for the year ended December 31, 2023. For the year, the company expects revenue of $4,295 million to $4,305 million compared to previous guidance of $4,310 million to $4,320 million. Guidance for the fiscal year 2023 excludes MDX Hawaii.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.54 USD | +3.97% |
|
+8.28% | -47.89% |
10/07 | Agilon Health Appoints Karthik Rao as Chief Medical Officer | MT |
10/07 | Agilon health, inc. Appoints Karthik Rao, M.D., as Chief Medical Officer | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.89% | 2.69B | |
-26.68% | 2.47B | |
-37.80% | 2.3B | |
-37.78% | 268M | |
+1.73% | 226M | |
-32.40% | 117M | |
-64.57% | 118M |
- Stock Market
- Equities
- AGL Stock
- News agilon health, inc.
- Agilon health, inc. Revises Earnings Guidance for the Year Ended December 31, 2023